keyword
MENU ▼
Read by QxMD icon Read
search

PMDD

keyword
https://www.readbyqxmd.com/read/28501679/factor-structure-and-longitudinal-measurement-invariance-of-phq-9-for-specialist-mental-health-care-patients-with-persistent-major-depressive-disorder-exploratory-structural-equation-modelling
#1
Boliang Guo, Catherine Kaylor-Hughes, Anne Garland, Neil Nixon, Tim Sweeney, Sandra Simpson, Tim Dalgleish, Rajini Ramana, Min Yang, Richard Morriss
BACKGROUND: The Patient Health Questionnaire-9 (PHQ-9) is a widely used instrument for measuring levels of depression in patients in clinical practice and academic research; its factor structure has been investigated in various samples, with limited evidence of measurement equivalence/invariance (ME/I) but not in patients with more severe depression of long duration. This study aims to explore the factor structure of the PHQ-9 and the ME/I between treatment groups over time for these patients...
May 8, 2017: Journal of Affective Disorders
https://www.readbyqxmd.com/read/28458114/altered-fractional-amplitude-of-low-frequency-fluctuation-in-premenstrual-syndrome-a-resting-state-fmri-study
#2
Hai Liao, Gaoxiong Duan, Peng Liu, Yanfei Liu, Yong Pang, Huimei Liu, Lijun Tang, Jien Tao, Danhong Wen, Shasha Li, Lingyan Liang, Demao Deng
BACKGROUND: Premenstrual syndrome (PMS) is becoming highly prevalent among female and is characterized by emotional, physical and behavior symptoms. Previous evidence suggested functional dysregulation of female brain was expected to be involved in the etiology of PMS. The aim of present study was to evaluate the alterations of spontaneous brain activity in PMS patients based on functional magnetic resonance imaging (fMRI). METHODS: 20 PMS patients and 21 healthy controls underwent resting-state fMRI scanning during luteal phase...
April 24, 2017: Journal of Affective Disorders
https://www.readbyqxmd.com/read/28427285/premenstrual-dysphoric-disorder-symptoms-following-ovarian-suppression-triggered-by-change-in-ovarian-steroid-levels-but-not-continuous-stable-levels
#3
Peter J Schmidt, Pedro E Martinez, Lynnette K Nieman, Deloris E Koziol, Karla D Thompson, Linda Schenkel, Paul G Wakim, David R Rubinow
OBJECTIVE: Premenstrual dysphoric disorder (PMDD) symptoms are eliminated by ovarian suppression and stimulated by administration of ovarian steroids, yet they appear with ovarian steroid levels indistinguishable from those in women without PMDD. Thus, symptoms could be precipitated either by an acute change in ovarian steroid levels or by stable levels above a critical threshold playing a permissive role in expression of an underlying infradian affective "pacemaker." The authors attempted to determine which condition triggers PMDD symptoms...
April 21, 2017: American Journal of Psychiatry
https://www.readbyqxmd.com/read/28319848/treatment-of-premenstrual-dysphoric-disorder-with-the-gabaa-receptor-modulating-steroid-antagonist-sepranolone-uc1010-a-randomized-controlled-trial
#4
Marie Bixo, Karin Ekberg, Inger Sundström Poromaa, Angelica Lindén Hirschberg, Aino Fianu Jonasson, Lotta Andréen, Erika Timby, Marianne Wulff, Agneta Ehrenborg, Torbjörn Bäckström
CONTEXT: Allopregnanolone is a metabolite from progesterone and a positive modulator of the GABAA receptor. This endogenous steroid may induce negative mood in sensitive women when present in serum levels comparable to the premenstrual phase. Its endogenous isomer, isoallopregnanolone, has been shown to antagonize allopregnanolone effects in experimental animal and human models. OBJECTIVE: The objective was to test whether inhibition of allopregnanolone by treatment with the GABAA modulating steroid antagonist (GAMSA) Sepranolone (UC1010) during the premenstrual phase could reduce symptoms of the premenstrual dysphoric disorder (PMDD)...
June 2017: Psychoneuroendocrinology
https://www.readbyqxmd.com/read/28257559/non-contraceptive-oestrogen-containing-preparations-for-controlling-symptoms-of-premenstrual-syndrome
#5
REVIEW
Bushra Naheed, Jan Herman Kuiper, Olalekan A Uthman, Fidelma O'Mahony, Patrick Michael Shaughn O'Brien
BACKGROUND: Premenstrual syndrome (PMS) is a psychological and somatic disorder of unknown aetiology, with symptoms typically including irritability, depression, mood swings, bloating, breast tenderness and sleep disturbances. About 3% to 10% of women who experience these symptoms may also meet criteria for premenstrual dysphoric disorder (PMDD). PMS symptoms recur during the luteal phase of the menstrual cycle and reduce by the end of menstruation. PMS results from ovulation and may be due to ovarian steroid interactions relating to neurotransmitter dysfunction...
March 3, 2017: Cochrane Database of Systematic Reviews
https://www.readbyqxmd.com/read/28243425/systematic-review-of-premenstrual-postmenstrual-and-infertility-disorders-of-vitex-agnus-castus
#6
REVIEW
Mahmoud Rafieian-Kopaei, Mino Movahedi
INTRODUCTION: Vitex agnus-castus, also called vitex is aboriginal to the Mediterranean region, with long leaves, tender stem, flowers and ripening seeds. The aim of this study was to overview premenstrual, postmenstrual and infertility disorder of Vitex agnus-castus. METHODS: This review article was carried out by searching studies in PubMed, Medline, Web of Science, and IranMedex databases. The initial search strategy identified about 87 references. In this study, 43 studies were accepted for further screening, and met all our inclusion criteria (in English, full text, therapeutic effects of Vitex agnus-castus and dated mainly from the year 2009 to 2016)...
January 2017: Electronic Physician
https://www.readbyqxmd.com/read/28193300/predictors-of-premenstrual-impairment-among-women-undergoing-prospective-assessment-for-premenstrual-dysphoric-disorder-a-cycle-level-analysis
#7
K M Schmalenberger, T A Eisenlohr-Moul, P Surana, D R Rubinow, S S Girdler
BACKGROUND: Women who experience significant premenstrual symptoms differ in the extent to which these symptoms cause cyclical impairment. This study clarifies the type and number of symptoms that best predict premenstrual impairment in a sample of women undergoing prospective assessment for premenstrual dysphoric disorder (PMDD) in a research setting. Central research goals were to determine (1) which emotional, psychological, and physical symptoms of PMDD are uniquely associated with premenstrual impairment, and (2) how many cyclical symptoms optimally predict the presence of a clinically significant premenstrual elevation of impairment...
February 14, 2017: Psychological Medicine
https://www.readbyqxmd.com/read/28044059/the-esc-e-z-complex-an-effector-of-response-to-ovarian-steroids-manifests-an-intrinsic-difference-in-cells-from-women-with-premenstrual-dysphoric-disorder
#8
N Dubey, J F Hoffman, K Schuebel, Q Yuan, P E Martinez, L K Nieman, D R Rubinow, P J Schmidt, D Goldman
Clinical evidence suggests that mood and behavioral symptoms in premenstrual dysphoric disorder (PMDD), a common, recently recognized, psychiatric condition among women, reflect abnormal responsivity to ovarian steroids. This differential sensitivity could be due to an unrecognized aspect of hormonal signaling or a difference in cellular response. In this study, lymphoblastoid cell line cultures (LCLs) from women with PMDD and asymptomatic controls were compared via whole-transcriptome sequencing (RNA-seq) during untreated (ovarian steroid-free) conditions and following hormone treatment...
January 3, 2017: Molecular Psychiatry
https://www.readbyqxmd.com/read/27993583/depression-in-individuals-with-traumatic-and-nontraumatic-spinal-cord-injury-living-in-the-community
#9
Joan Saurí, Andrés Chamarro, Anna Gilabert, Mariona Gifre, Neus Rodriguez, Raquel Lopez-Blazquez, Lluïsa Curcoll, Jesús Benito-Penalva, Dolors Soler
OBJECTIVE: To assess depression in a sample of individuals with spinal cord injury (SCI) living in the community, and to determine the prevalence of probable major depressive disorder (PMDD) among those with traumatic spinal cord injury (T-SCI) and those with nontraumatic spinal cord injury (NT-SCI). DESIGN: Cross-sectional. SETTING: Data were collected on individuals with SCI now living in the community, who completed a comprehensive follow-up assessment at the hospital...
December 16, 2016: Archives of Physical Medicine and Rehabilitation
https://www.readbyqxmd.com/read/27901212/validation-of-the-brazilian-portuguese-version-of-the-premenstrual-symptoms-screening-tool-psst-and-association-of-psst-scores-with-health-related-quality-of-life
#10
Rachel de A Câmara, Cristiano A Köhler, Benicio N Frey, Thomas N Hyphantis, André F Carvalho
Objective: To develop and validate a Brazilian Portuguese version of the Premenstrual Symptoms Screening Tool (PSST), a questionnaire used for the screening of premenstrual syndrome (PMS) and of the most severe form of PMS, premenstrual dysphoric disorder (PMDD). The PSST also rates the impact of premenstrual symptoms on daily activities. Methods: A consecutive sample of 801 women aged ≥ 18 years completed the study protocol. The internal consistency, test-retest reliability, and content validity of the Brazilian PSST were determined...
November 24, 2016: Revista Brasileira de Psiquiatria
https://www.readbyqxmd.com/read/27798029/stress-fracture-and-premenstrual-syndrome-in-japanese-adolescent-athletes-a-cross-sectional-study
#11
Takashi Takeda, Yoko Imoto, Hiroyo Nagasawa, Atsuko Takeshita, Masami Shiina
OBJECTIVES: To investigate the relationship between the occurrence of stress fracture and premenstrual syndrome (PMS)/premenstrual dysphoric disorder (PMDD) in Japanese adolescent athletes. DESIGN: Cross-sectional study. SETTING: Osaka, Japan. PARTICIPANTS: A school-based survey on menstruation and school life was conducted using a sample of 1818 Japanese female students who belonged to two public high schools in Japan...
October 18, 2016: BMJ Open
https://www.readbyqxmd.com/read/27607359/affective-temperaments-and-emotional-traits-are-associated-with-a-positive-screening-for-premenstrual-dysphoric-disorder
#12
Rachel A Câmara, Cristiano A Köhler, Michael Maes, Paulo R Nunes-Neto, André R Brunoni, João Quevedo, Brisa S Fernandes, Giulio Perugi, Thomas N Hyphantis, André F Carvalho
OBJECTIVES: Preliminary evidence indicates that premenstrual dysphoric disorder (PMDD) may be frequently co-morbid with bipolar spectrum disorders. In addition, the manifestations of PMDD seem similar to a subthreshold depressive mixed state. Nevertheless, the associations between PMDD and affective temperaments and emotional traits have not been previously investigated. METHODS: A consecutive sample of 514 drug-free Brazilian women (mean age: 22.8; SD=5.4years) took part in this cross-sectional study...
August 18, 2016: Comprehensive Psychiatry
https://www.readbyqxmd.com/read/27538401/emotional-regulation-difficulties-and-premenstrual-symptoms-among-israeli-students
#13
Inbal Reuveni, Dan Rotem, Segman Ronen, Evron Ron, Laufer Sofia, Goelman Gadi, Bonne Omer, Canetti Laura
Premenstrual dysphoric disorder (PMDD) is a severe form of premenstrual syndrome (PMS) reported to affect 3-8 % of women of reproductive age and resulting in marked emotional and occupational impairment. Despite its prevalence, the etiology of PMDD is largely unknown, and patients remain mostly undiagnosed and poorly treated. It has been suggested that PMDD is a manifestation of underlying depressive disorder which is associated with the inability to regulate emotions in an adaptive manner. Therefore, we hypothesized that women with PMDD would exhibit increased difficulty with emotional regulation...
August 18, 2016: Archives of Women's Mental Health
https://www.readbyqxmd.com/read/27523500/toward-the-reliable-diagnosis-of-dsm-5-premenstrual-dysphoric-disorder-the-carolina-premenstrual-assessment-scoring-system-c-pass
#14
Tory A Eisenlohr-Moul, Susan S Girdler, Katja M Schmalenberger, Danyelle N Dawson, Pallavi Surana, Jacqueline L Johnson, David R Rubinow
OBJECTIVE: Despite evidence for the validity of premenstrual dysphoric disorder (PMDD) and the inclusion of the disorder in DSM-5, variable diagnostic practices compromise the construct validity of the diagnosis and threaten the clarity of efforts to understand and treat its underlying pathophysiology. In an effort to hasten and streamline the translation of the DSM-5 criteria for PMDD into terms compatible with existing research practices, the authors present the development and initial validation of the Carolina Premenstrual Assessment Scoring System (C-PASS)...
January 1, 2017: American Journal of Psychiatry
https://www.readbyqxmd.com/read/27521647/development-of-a-screening-instrument-to-assess-premenstrual-dysphoric-disorder-as-conceptualized-in-dsm-5
#15
Leire Aperribai, Itziar Alonso-Arbiol, Nekane Balluerka, Laurence Claes
OBJECTIVE: This study aimed at developing and validating a screening instrument to assess premenstrual dysphoric disorder (PMDD) based on DSM-5 criteria, which is not yet available. METHODS: The Premenstrual Dysphoric Disorder Questionnaire for DSM-5 (Cuestionario del Trastorno Disfórico Premenstrual - DSM-5), a 25-item questionnaire to assess PMDD was developed and completed in Spanish by 2820 women (Age M=23.43; SD=7.87). Exploratory factor analysis (N=1410) and confirmatory factor analysis (N=1410) were performed in randomly selected subsamples...
September 2016: Journal of Psychosomatic Research
https://www.readbyqxmd.com/read/27454391/premenstrual-dysphoric-disorder-without-comorbid-psychiatric-conditions-a-systematic-review-of-therapeutic-options
#16
REVIEW
Gianna Sepede, Fabiola Sarchione, Ilaria Matarazzo, Massimo Di Giannantonio, Rosa Maria Salerno
OBJECTIVES: Premenstrual dysphoric disorder (PMDD) is a disabling condition affecting approximately 2% to 8% of women during reproductive age. It has been recently included in the mood disorder section of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, but its treatment as a primary psychiatric illness is still debated, because of the high prevalence of other mental disturbances in PMDD patients. On the other hand, clear clinical guidelines for PMDD patients not suffering from comorbid mental conditions are not yet available...
September 2016: Clinical Neuropharmacology
https://www.readbyqxmd.com/read/27385849/prevalence-of-premenstrual-syndrome-and-premenstrual-dysphoric-disorder-among-college-students-of-bhavnagar-gujarat
#17
Chintan Madhusudan Raval, Bharat Navinchandra Panchal, Deepak Sachidanand Tiwari, Ashok Ukabhai Vala, Renish Bhupendrabhai Bhatt
BACKGROUND: Premenstrual dysphoric disorder (PMDD) is a severe form of premenstrual syndrome (PMS) characterized by mood changes, anxiety, and somatic symptoms experienced during the specific time of menstrual cycle. Prevalence data of PMS and PMDD is sparse among college girls in India. AIMS: The aim of this study is to study the prevalence of PMS and PMDD among college students of Bhavnagar (Gujarat), its associated demographic and menstrual factors, to rank common symptoms and compare premenstrual symptom screening tool (PSST) with Structured Clinical Interview for DSM-IV-TR defined PMDD (SCID-PMDD) for sensitivity and specificity...
April 2016: Indian Journal of Psychiatry
https://www.readbyqxmd.com/read/27378657/precise-and-accurate-assay-of-pregnenolone-and-five-other-neurosteroids-in-monkey-brain-tissue-by-lc-ms-ms
#18
Alain Y Dury, Yuyong Ke, Fernand Labrie
A series of steroids present in the brain have been named "neurosteroids" following the possibility of their role in the central nervous system impairments such as anxiety disorders, depression, premenstrual dysphoric disorder (PMDD), addiction, or even neurodegenerative disorders such as Alzheimer's and Parkinson's diseases. Study of their potential role requires a sensitive and accurate assay of their concentration in the monkey brain, the closest model to the human. We have thus developed a robust, precise and accurate liquid chromatography-tandem mass spectrometry method for the assay of pregnenolone, pregnanolone, epipregnanolone, allopregnanolone, epiallopregnanolone, and androsterone in the cynomolgus monkey brain...
September 2016: Steroids
https://www.readbyqxmd.com/read/27355449/a-symptom-diary-to-assess-severe-premenstrual-syndrome-and-premenstrual-dysphoric-disorder
#19
Carolyn Janda, Johanna N Kues, Gerhard Andersson, Maria Kleinstäuber, Cornelia Weise
The differentiation between premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) has been widely discussed. PMDD is listed as a mental disorder in the DSM-5, whereas PMS is not considered as a mental disorder in any diagnostic manual. Consequently, PMS is operationalized in different ways. Keeping a symptom diary is required to diagnose PMDD but is also recommended for PMS. The aim of our study was, therefore, to operationalize PMS and PMDD within a DSM-5-based symptom diary. We developed a symptom-intensity-score (SI-score) and an interference-score (INT-score) to evaluate the symptom diary...
June 29, 2016: Women & Health
https://www.readbyqxmd.com/read/27212819/premenstrual-dysphoric-disorder-in-medical-students-residing-in-hostel-and-its-association-with-lifestyle-factors
#20
Amrita Mishra, Girish Banwari, Priyanka Yadav
CONTEXT: There is scant research on premenstrual syndrome (PMS) and its more severe counterpart, premenstrual dysphoric disorder (PMDD) in Indian females. This study aimed to evaluate symptoms of PMS in medical students and to find the association of sociodemographic variables and lifestyle factors with PMDD. SUBJECTS AND METHODS: A total of 179 medical students residing in the hostel of an Indian medical college and its affiliated teaching hospital were approached, of which 100 (55...
July 2015: Industrial Psychiatry Journal
keyword
keyword
26920
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"